The practice of genetic medicine requires a broad range of expertise including an understanding of the molecular and cellular biology that comprises the basis of gene transfer, a sense of the complexity and precision required to undertake clinical research, and finally an appreciation of the ethnical issues that are unique to the interface of science and humanity. The Training and Education Core of the Weill Cornell Program in Excellence in Gene Therapy (PEGT) takes as its mission to create a framework within which both experienced investigators and novice investigators can pursue a better understanding of their discipline. To accomplish this task, the Training and Education Core sets forth three venues in which education and training can occur. First, formal training programs are in place for each level of investigator. These programs include summer research programs for undergraduate students, laboratory projects and graduate level courses for graduate students, specialized training programs for postgraduate investigators, and technical training sessions and topical symposia for professional investigators. The keystone of the training program is the Weill Cornell PEGT Scholars Program which will recruit and training investigators holding PhD, MD, or MD/PhD degrees for PEGT Scholars Program which will recruit and train investigators holding PhD, MD, or MD/PhD degrees for an intensive two-year immersion into all aspects of genetic medicine. The Scholars Program incorporates comprehensive training in laboratory techniques, clinical research, regulatory affairs, and ethics, and permit the Scholar to concentrate in the area of his or her choosing. The goal of the Scholars Program is to develop a cadre of genetic medicine researchers who have a global appreciation for the elements of genetic medicine that must come together to take research from the bench to the bedside. The second venue for the Training and Education Core is the establishment of communication among investigators through seminar series, a webpage, and long distance meeting/learning facilities. The final venue of the Training and Education Core is public outreach. Weill Cornell PEGT investigators will continue to pursue opportunities for positive and open interactions with the lay public who are both the intended beneficiaries and principal benefactors of our work.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL066952-02
Application #
6501594
Study Section
Special Emphasis Panel (ZHL1)
Project Start
2001-09-01
Project End
2002-08-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
$199,380
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Chiuchiolo, Maria J; Crystal, Ronald G (2016) Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease. Ann Am Thorac Soc 13 Suppl 4:S352-69
Nolan, Daniel J; Ginsberg, Michael; Israely, Edo et al. (2013) Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev Cell 26:204-19
Wang, Lan; Rosenberg, Jonathan B; De, Bishnu P et al. (2012) In vivo gene transfer strategies to achieve partial correction of von Willebrand disease. Hum Gene Ther 23:576-88
Krause, Anja; Whu, Wen Zhu; Xu, Yaqin et al. (2011) Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF. Vaccine 29:2131-9
Kobayashi, Hideki; Butler, Jason M; O'Donnell, Rebekah et al. (2010) Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol 12:1046-56
Shmelkov, Sergey V; Hormigo, Adília; Jing, Deqiang et al. (2010) Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med 16:598-602, 1p following 602
Rabbany, Sina Y; James, Daylon; Rafii, Shahin (2010) New dimensions in vascular engineering: opportunities for cancer biology. Tissue Eng Part A 16:2157-9
Wang, G; Qiu, J; Wang, R et al. (2010) Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer. Cancer Gene Ther 17:559-70
Yamamoto, Masaya; James, Daylon; Li, Hui et al. (2010) Generation of stable co-cultures of vascular cells in a honeycomb alginate scaffold. Tissue Eng Part A 16:299-308
Watanabe, M; Boyer, J L; Crystal, R G (2010) AAVrh.10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-VEGF to suppress growth of metastatic lung tumors. Gene Ther 17:1042-51

Showing the most recent 10 out of 61 publications